Sana Biotechnology Inc.

AI Score

XX

Unlock

1.59
-0.12 (-7.02%)
At close: Mar 31, 2025, 10:20 AM

Sana Biotechnology Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -1.41 -2.8 -2.79 -7.49 -23.62 -50.28 -496.39
PEG Ratio 0.07 -0.79 0.09 -0.19 -0.21 -0.06 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 1.50 2.76 1.49 3.54 -15.63 -46.13 -498.61
P/FCF Ratio -1.47 -2.9 -2.39 -9.17 -40.66 -58.88 -471.2
P/OCF Ratio -1.69 -3.13 -2.56 -10.26 -47.7 -76.9 -487.26
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.38 0.36 0.22 0.15 -0.17 -0.34 n/a
Quick Ratio 3.54 3.31 3.99 5.62 12.22 7.28 18.26
Current Ratio 3.54 3.31 3.99 5.62 12.22 7.28 18.26
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -1.06 -0.99 -0.53 -0.47 0.66 0.92 1.00
Return on Assets (ROA) -0.53 -0.5 -0.32 -0.3 -0.38 -0.31 -0.39
Return on Capital (ROIC) -0.6 -0.65 -0.38 -0.35 -0.41 -0.36 -0.25
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a